← Open Payments lookup

LINDA ABAD: Open Payments

NPI 1063928240 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$923 in 10 payments from 8 companies in 2025. Trend: 2023 $190 · 2024 $360 · 2025 $923

Food & beverage: $923
CompanyPaymentsAmount
ABBVIE INC.3$261
ABIOMED1$126
Alcresta Therapeutics, Inc.1$124
Actelion Pharmaceuticals US, Inc.1$124
Fresenius Kabi USA, LLC1$123
Mallinckrodt Hospital Products Inc.1$108
Merck Sharp & Dohme LLC1$33
Alexion Pharmaceuticals, Inc.1$25

Products named: EMBLAVEO, RELIZORB, UPTRAVI, Smoflipid, TERLIVAZ, ZERBAXA, ULTOMIRIS, AVYCAZ.

Industry payments across TX — which companies pay providers there.